Name: 글로벌 시장 동향
SKU: HCIT3087
Availability: InStock

보고서 요약(국문)

웨스턴 블롯팅은 단백질의 상대적 분자량을 기반으로 특정 단백질을 분리하고 검출하는 데 사용되는 분석 기술입니다. 웨스턴 블롯팅 프로세서는 높은 감도와 특이성을 달성하여 원하는 단백질을 검출 한계보다 거의 10배 낮은 농도에서도 검출할 수 있도록 웨스턴 블롯팅 기술을 수행하는 데 사용되는 장치입니다. 기존 웨스턴 블롯팅 프로세서를 사용한 결과는 상대적으로 신뢰성이 떨어지고 번거로우며 전문적인 기술이 필요하지만, 자동화된 웨스턴 블롯팅 프로세서는 이러한 문제점을 해결합니다. 시장 성장을 이끄는 주요 요인으로는 HIV/AIDS 유병률 증가, 제약 및 생명공학 기업의 연구 개발 투자 증가, 그리고 신흥 시장의 잠재적 기회 등이 있습니다.
웨스턴 블롯팅 프로세서 시장 동향:
프로테오믹스 연구에서 웨스턴 블롯팅 프로세서의 채택 증가가 시장 성장을 견인합니다.
웨스턴 블롯팅 프로세서 시장은 프로테오믹스 및 게놈 연구에 의해 크게 성장하고 있습니다. 웨스턴 블롯팅은 분자 생물학 및 프로테오믹스에서 가장 일반적으로 사용되는 기술 중 하나입니다. 순차적인 프레임워크이기 때문에 어느 단계에서든 차이나 오류가 발생할 수 있어 이 특정 방법의 재현성과 신뢰성이 저하됩니다. 프로테오믹스 접근법에는 단백질 번역 후 변형, 단백질-단백질 상호작용, 단백질 회전율 등의 특성 분석 및 식별이 포함됩니다. 효율적인 맞춤형 의약품 개발에 대한 관심이 높아짐에 따라 전 세계적으로 웨스턴 블롯팅 프로세서에 대한 수요가 증가하고 있습니다.
또한, 맞춤형 의약품에 대한 관심 증가는 예측 기간 동안 시장 성장에 기여할 것입니다. 암 치료를 위한 맞춤형 의약품의 도입이 증가함에 따라 웨스턴 블롯팅 프로세서의 도입도 증가하고 있습니다. 맞춤형 의약품은 최적의 치료 효과와 높은 안전성을 제공하여 환자에게 더 나은 의료 서비스를 제공할 수 있는 잠재력을 가지고 있습니다. 맞춤형 의약품은 의료 서비스의 여러 측면을 개선하고 비용을 절감할 수 있는 잠재력을 가지고 있으며, 이는 시장 성장의 긍정적인 지표가 될 것으로 예상됩니다. 맞춤형 의약품 연합(Personalized Medicine Coalition)에 따르면, 바이오제약 연구원들은 향후 5년 동안 개발 중인 맞춤형 의약품의 수가 69% 증가할 것으로 예측하고 있습니다.

웨스턴 블롯팅 프로세서 시장 세분화:
질병 진단 부문은 예측 기간 동안 시장에서 가장 빠른 성장을 보일 것으로 예상됩니다.
응용 분야를 기준으로 웨스턴 블롯팅 프로세서 시장은 생의학 및 생화학 연구, 질병 진단, 농업 및 기타로 분류됩니다.
질병 진단 부문은 2022년 웨스턴 블롯팅 프로세서 시장을 주도했습니다. 이는 전 세계적으로 간염 및 라임병과 같은 대상 질환의 발생률이 증가하고 있기 때문입니다. 진단 검사는 질병의 진단 또는 발견을 돕기 위해 수행되는 의료 검사의 일종입니다. 질병 진단 검사는 이미 질병이 있는 사람들에게 예후 정보를 제공하는 데 사용됩니다. 의료 전문가는 증상과 징후를 단서로 활용하여 질병 발생 시 가장 가능성이 높은 진단을 내립니다. 또한, 단백질체학 및 유전학 분야에서 단백질 샘플 혼합물에서 특정 단백질 분자를 식별하는 데 이러한 장치를 사용하는 것은 예측 기간 동안 시장 성장을 견인할 주요 요인으로 예상됩니다.

최종 사용자를 기준으로 웨스턴 블롯팅 프로세서 시장은 학술 및 연구 기관, 제약 및 생명공학 회사, 진단 센터 및 기타로 분류됩니다.
학술 및 연구 기관은 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 학술 및 연구 실험실에서 진행되는 다양한 연구 활동이 웨스턴 블롯팅 프로세서에 대한 수요를 증가시키고 있습니다. 주요 수요는 미국, 영국, 독일과 같은 선진국 및 신흥 국가에서 발생합니다.
웨스턴 블롯팅 프로세서 시장의 지역별 분포:
북미는 예측 기간 동안 시장을 주도할 지역입니다.
이 연구는 북미, 남미, 유럽, 아시아 태평양 및 중동 및 아프리카를 포함한 전 세계 웨스턴 블롯팅 프로세서 시장을 지역별로 분석합니다.
북미는 전 세계 웨스턴 블롯팅 프로세서 시장에서 가치와 물량 모두에서 가장 큰 점유율을 차지하며 시장을 주도했고, 그 뒤를 유럽과 아시아 태평양이 이었습니다. 2022년 북미 웨스턴 블롯 프로세서 시장은 미국이 주도했습니다. 이는 라임병과 HIV의 확산 증가, 연구 자금 지원 확대, 유전자 변형 작물 생산 증가, 그리고 연구 컨퍼런스 개최 건수 증가에 기인합니다. 미국의 주요 기업들은 새로운 학습 센터를 설립하여 시장 성장에 기여하고 있습니다. 예를 들어, 바이오래드(Bio-Rad)는 2021년 1월 웨스턴 블롯 학습 센터와 온라인 학습 플랫폼을 개설하여 연구자들이 웨스턴 블롯 실험을 개선하는 데 필요한 정보와 지침을 제공하고 있습니다. 이 학습 센터는 bio-rad.com에서 이용 가능하며, 웨스턴 블롯의 과학적 원리, 모범 사례, 유용한 팁과 기술, 그리고 실험 문제 해결 방법에 대한 포괄적인 정보를 제공합니다.
또한, 아시아 태평양 지역은 예측 기간 동안 웨스턴 블롯 프로세서 시장에서 가장 빠른 성장률을 보일 것으로 예상됩니다. 중국이 시장을 주도하고 있으며, 인도 역시 아시아 태평양 웨스턴 블롯 프로세서 시장에서 상당한 성장세를 나타낼 것으로 전망됩니다.

웨스턴 블롯팅 프로세서 기업 및 경쟁 환경:
웨스턴 블롯팅 프로세서 시장은 수많은 브랜드가 경쟁하고 있어 경쟁이 매우 치열합니다. 주요 웨스턴 블롯팅 프로세서 업체로는 Bio-Rad Laboratories, Inc., Cell Signaling Technology, Advansta Inc., Li-Cor Biosciences, Bio-Techne Corporation, GE Healthcare, Cytoskeleton Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA 등이 있습니다. 이들 주요 업체는 웨스턴 블롯팅 프로세서 시장의 글로벌 성장을 위해 신제품 출시 및 확장 전략을 적극적으로 추진하고 있습니다. 일부 주요 업체는 인수합병 전략을 통해 사업을 확장하고 있습니다. 예를 들어, Bio-Techne는 2021년 4월 Asuragen, Inc.를 인수했습니다. 이 인수를 통해 유전자 스크리닝, 종양 진단 키트, 분자 대조군 등 최고 수준의 분자 진단 및 연구 제품 포트폴리오를 강화할 수 있었습니다. 또한, 2022년 7월 Bio-Techne는 Namocell, Inc. 인수를 완료했다고 발표했습니다. 이 인수를 통해 세포에 손상을 주지 않고 세포 생존력과 무결성을 유지하는 사용하기 쉬운 단일 세포 분류 및 분주 플랫폼을 확보하게 되었습니다. 2022년 1월, Bio-Techne는 Jess의 자동 웨스턴 블롯팅 시스템용 고감도 형광 검출 Stellar NIR/IR 모듈의 상용 출시를 발표했습니다. 이 새로운 모듈은 동일한 검출 레인에서 여러 분석 물질을 동시에 검출하면서 저농도 단백질을 검출할 수 있도록 합니다. 이 모듈은 웨스턴 블롯팅 형광 검출 감도에 대한 새로운 업계 표준을 제시합니다.
COVID-19 영향: 전 세계 웨스턴 블롯팅 프로세서 시장에 긍정적인 영향.
COVID-19 관련 웨스턴 블롯팅 프로세서의 활용 증가에 힘입어 2020년 웨스턴 블롯팅 프로세서 시장 가치가 상승할 것으로 예상됩니다. 웨스턴 블롯은 ELISA와 같은 선별 검사에서 양성 또는 경계 양성 결과를 확인하는 데 고려될 수 있습니다. 웨스턴 블롯의 또 다른 이점은 백신 개발의 기반이 될 수 있는 항원을 식별하는 데 도움이 된다는 것입니다. 웨스턴 블롯 기술은 COVID-19에서 회복된 환자의 혈청이 인식하는 단백질 항원을 확인하는 데 사용되어, 특히 생백신이나 약독화 바이러스를 사용하지 않는 경우, 단일가 백신이나 백신 칵테일에 포함되어야 할 바이러스 구성 요소를 더 잘 식별할 수 있습니다. 이러한 요인들은 웨스턴 블롯 프로세서 시장에 대한 수요 증가로 인해 팬데믹 기간 동안 웨스턴 블롯의 필요성이 증가했음을 나타냅니다. 따라서 COVID-19 팬데믹 속에서 웨스턴 블롯 프로세서에 대한 수요가 증가했고, 이는 2020년 매출 증가로 이어졌습니다.
글로벌 웨스턴 블롯 프로세서 시장 보고서는 약 61개의 시장 데이터 표, 54개의 그림 및 170페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Western blotting is an analytical technique used to separate and detect specific proteins based on the relative molecular mass of proteins. Western blotting processors are devices used to do western blotting techniques to attain high sensitivity and specificity, facilitating detection of preferred protein with a concentration nearly ten times lesser than the threshold of detection. The results attained with the conventional western blotting processors are relatively unreliable, tedious and require technical expertise, which is addressed by the automated western blot processors. Certain factors leading the market growth include the increasing prevalence of HIV/AIDS, the increasing R&D expenditure by pharmaceutical and biotechnology companies, and untapped opportunities in emerging markets.
Western Blotting Processors Market Dynamics:
Rising adoption of western blotting processor in increasing proteomics research drives market growth
The market for western blotting processors is considerably driven by proteomics and genomics research. Western blotting is one of the most commonly used techniques in molecular biology and proteomics. Because it is a sequential framework, differences and inaccuracies could even take place at any stage, decreasing this particular method's reproducibility and reliability. Proteomics approaches include the characterization and identification of post-translational modifications, protein-protein interaction, protein turnovers, and more. With the rising focus on the development of efficient, personalized medicine, the demand for western blotting processors is increasing globally.
Also, increasing focus on personalized medicine helps to grow the market in the forecast period. The increasing adoption of personalized medicines for cancer is augmenting the adoption of western blotting processors. Personalized medicine has the potential to provide the best response and highest safety margin to ensure better patient care. Personalized medicine has the potential to improve several aspects of healthcare while lowering costs, which is expected to be a positive indicator of the growth of the market. According to Personalized Medicine Coalition, biopharmaceutical researchers predict a 69% increase in the number of personalized medicines in development over the next five years.
Western Blotting Processors Market Segmentation:
Disease diagnostics segment will project the fastest growth in the market throughout the forecast period
Based on the application, the western blotting processors market has been classified into biomedical & biochemical research, disease diagnostics, agriculture, and others.
The disease diagnostics segment dominated the western blotting processor market in 2022. This is due to a rise in the increasing incidences of target diseases, such as Hepatitis and Lyme disease, across the globe. A diagnostics test is a kind of medical test performed to aid in the diagnosis or detection of a disease. Disease diagnostic tests are used to provide prognostic information on people with established diseases. Healthcare professionals use symptoms and signs as clues that can help to determine the most likely diagnosis when illness is present. Moreover, the use of these devices to identify specific protein molecules from a mixture of protein samples in proteomics and genetic science are certain key factors expected to drive market growth in the forecast period.
Based on the end-user, the western blotting processors market has been classified into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others.
Academic & research institutes lead the market throughout the forecast period. Several research activities ongoing in the academic & research laboratories are augmenting the demand for western blotting processors. The major demand is driven across the developed and emerging nations, such as the United States, United Kingdom and Germany.
Western Blotting Processors Market Geographical Penetration:
North America is the dominating region during the forecast period.
Based on geography, the study analyzes the western blotting processors market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.
North America dominated the global western blotting processors market with the largest share in value and volume globally, followed by Europe and the Asia Pacific. The United States dominated the North American western blotting processors market in 2022. It is owing to the increasing prevalence of Lyme disease and HIV, the rise in research funding and growing production of genetically modified crops, and the rising number of research conferences. Some major key players in the United States help grow the the market by launching new learning centers. For instance, in January 2021, Bio-Rad laboratory launched its Western Blot Learning Centre and online learning platform, which provide information and guidance to help researchers to improve their experimental western blotting. This learning Centre is available on bio-rad.com. This Centre offered comprehensive information on the science of western blotting, best practices, tips and techniques, and guidance on troubleshooting experiments.
Moreover, Asia Pacific is expected to project the fastest growth rate in the western blotting processors market during the forecast period. China dominates the market, whereas India is estimated to exhibit considerable growth in the Asia Pacific western blotting processors market during the forecast period.
Western Blotting Processors Companies and Competitive Landscape:
The western blotting processors market is highly competitive, owing to the large presence of western blotting processors brands. The key western blotting processors players include Bio-Rad Laboratories, Inc., Cell Signaling Technology, Advansta Inc., Li-Cor Biosciences, Bio-Techne Corporation, GE Healthcare, Cytoskeleton Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA. The crucial players are adopting new product launches and expansion strategies for global growth in the western blotting processors. Some major key players follow merger and acquisition strategies to expand their business. For instance, in April 2021, Bio-techne completed the acquisition of Asuragen, Inc. This acquisition helped to increase the product portfolio of best-in-class molecular diagnostic and research products like genetic screening, oncology testing kits, and molecular controls. Also, in July 2022, Bio-Techne announced it had completed the acquisition of Namocell, Inc. This acquisition adds easy-to-use single-cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. In January 2022, Bio-techne announced the commercial release of high sensitivity fluorescent detection stellar NIR / IR modules for jess's automated western blotting system. This new module allowed the detection of low abundance proteins while multiplexing multiple analytes within the same detection lane. This module sets a new industry standard for western blotting fluorescence detection sensitivity.
COVID-19 Impact: Positive impact on the global western blotting processors market.
An increase in the market value of western blotting processors is expected in 2020, backed by the increasing application of western blotting processors in COVID-19. Western blots should be considered for confirming a positive or borderline-positive result from a screening test, such as an ELISA. An additional benefit of Western blots would be to identify antigens that could form the basis for developing a vaccine. Western blot technic used to determine which protein antigens are recognized by sera from patients recovering from COVID-19 in order to better identify those components of the virus that should be part of a monovalent vaccine or a vaccine cocktail, especially if a live, attenuated virus is not used. These factors indicated that the need for western blotting increased during the pandemic owing to increasing demand for the western blotting processors market. Therefore, the demand for western blotting processors increased amid the COVID-19 pandemic, which in turn, increased its sales in 2020.
The global western blotting processors market report would provide an access to approximately 61 market data tables, 54 figures and 170 pages

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by End User
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of HIV/AIDS
4.1.1.2. Rise in R&D spending by pharmaceutical companies
4.1.2. Restraints:
4.1.2.1. Emergence of alternatives
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
7.3. Market Attractiveness Index, By Product Segment
7.3.1. Consumables*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Instruments
8. By Application
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
8.3.1. Biomedical & Biochemical Research*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Disease Diagnostic
8.3.3. Agriculture
8.3.4. Others
9. By End User
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
9.3. Market Attractiveness Index, By End User Segment
9.3.1. Academic & Research Institutes*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Pharmaceutical & Biotechnology Companies
9.3.3. Diagnostic Centers
9.3.4. Others
10. By Region
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. U.S.
10.4.6.2. Canada
10.4.6.3. Mexico
10.5. Europe
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. Germany
10.5.6.2. U.K.
10.5.6.3. France
10.5.6.4. Italy
10.5.6.5. Spain
10.5.6.6. Rest of Europe
10.6. South America
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.6.6.1. Brazil
10.6.6.2. Argentina
10.6.6.3. Rest of South America
10.7. Asia Pacific
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.7.6.1. China
10.7.6.2. India
10.7.6.3. Japan
10.7.6.4. Australia
10.7.6.5. Rest of Asia Pacific
10.8. Middle East and Africa
10.8.1. Introduction
10.8.2. Key Region-Specific Dynamics
10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Western Blotting Processors Market- Company Profiles
12.1. Bio-Rad Laboratories, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Bio-Techne Corporation
12.3. Advansta Inc.
12.4. Cell Signaling Technology
12.5. Li-Cor Biosciences
12.6. Cytoskeleton Inc.
12.7. GE Healthcare
12.8. PerkinElmer Inc.
12.9. Merck KGaA
12.10. F. Hoffmann-La Roche Ltd. (List Not Exhaustive)
13. Premium Insights
14. DataM Intelligence
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

언급된 주요 기업들

Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Advansta Inc., Cell Signaling Technology, Li-Cor Biosciences, Cytoskeleton Inc., GE Healthcare, PerkinElmer Inc., Merck KGaA

표 목록 (Tables)

List of Tables

Table 1 Global Western Blotting Processors Market Value, By Product, 2021, 2025 & 2029 ($ Million)

Table 2 Global Western Blotting Processors Market Value, By Application, 2021, 2025 & 2029 ($ Million)

Table 3 Global Western Blotting Processors Market Value, BY END User, 2021, 2025 & 2029 ($ Million)

Table 4 Global Western Blotting Processors Market Value, By Region, 2021, 2025 & 2029 ($ Million)

Table 5 Global Western Blotting Processors Market Value, By Product, 2021, 2025 & 2029 ($ Million)

Table 6 Global Western Blotting Processors Market Value, By Product, 2020-2029 ($ Million)

Table 7 Global Western Blotting Processors Market Value, By Application, 2021, 2025 & 2029 ($ Million)

Table 8 Global Western Blotting Processors Market Value, By Application, 2020-2029 ($ Million)

Table 9 Global Western Blotting Processors Market Value, BY END User, 2021, 2025 & 2029 ($ Million)

Table 10 Global Western Blotting Processors Market Value, By End User, 2020-2029 ($ Million)

Table 11 Global Western Blotting Processors Market Value, By Region, 2021, 2025 & 2029 ($ Million)

Table 12 Global Western Blotting Processors Market Value, By Region, 2020-2029 ($ Million)

Table 13 North America Western Blotting Processors Market Value, By Product, 2020-2029 ($ Million)

Table 14 North America Western Blotting Processors Market Value, By Application, 2020-2029 ($ Million)

Table 15 North America Western Blotting Processors Market Value, BY END User, 2020-2029 ($ Million)

Table 16 North America Western Blotting Processors Market Value, By Country, 2020-2029 ($ Million)

Table 17 South America Western Blotting Processors Market Value, By Product, 2020-2029 ($ Million)

Table 18 South America Western Blotting Processors Market Value, By Application, 2020-2029 ($ Million)

Table 19 South America Western Blotting Processors Market Value, By End User, 2020-2029 ($ Million)

Table 20 South America Western Blotting Processors Market Value, By Country, 2020-2029 ($ Million)

Table 21 Europe Western Blotting Processors Market Value, By Product, 2020-2029 ($ Million)

Table 22 Europe Western Blotting Processors Market Value, By Application, 2020-2029 ($ Million)

Table 23 Europe Western Blotting Processors Market Value, BY END User, 2020-2029 ($ Million)

Table 24 Europe Western Blotting Processors Market Value, By Country, 2020-2029 ($ Million)

Table 25 Asia-Pacific Western Blotting Processors Market Value, By Product, 2020-2029 ($ Million)

Table 26 Asia-Pacific Western Blotting Processors Market Value, By Application, 2020-2029 ($ Million)

Table 27 Asia-Pacific Western Blotting Processors Market Value, BY END User, 2020-2029 ($ Million)

Table 28 Asia-Pacific Western Blotting Processors Market Value, By Country, 2020-2029 ($ Million)

Table 29 Middle East & Africa Western Blotting Processors Market Value, By Product, 2020-2029 ($ Million)

Table 30 Middle East & Africa Western Blotting Processors Market Value, By Application, 2020-2029 ($ Million)

Table 31 Middle East & Africa Western Blotting Processors Market Value, By End User, 2020-2029 ($ Million)

Table 32 Bio-Rad Laboratories, Inc.: Overview

Table 33 Bio-Rad Laboratories, Inc.: Product Portfolio

Table 34 Bio-Rad Laboratories, Inc.: Key Developments

Table 35 Bio-Techne Corporation: Overview

Table 36 Bio-Techne Corporation: Product Portfolio

Table 37 Bio-Techne Corporation: Key Developments

Table 38 Advansta Inc.: Overview

Table 39 Advansta Inc.: Product Portfolio

Table 40 Advansta Inc.: Key Developments

Table 41 Cell Signaling Technology: Overview

Table 42 Cell Signaling Technology: Product Portfolio

Table 43 Cell Signaling Technology: Key Developments

Table 44 Li-Cor Biosciences: Overview

Table 45 Li-Cor Biosciences: Product Portfolio

Table 46 Li-Cor Biosciences: Key Developments

Table 47 Cytoskeleton Inc.: Overview

Table 48 Cytoskeleton Inc.: Product Portfolio

Table 49 Cytoskeleton Inc.: Key Developments

Table 50 GE Healthcare: Overview

Table 51 GE Healthcare: Product Portfolio

Table 52 GE Healthcare: Key Developments

Table 53 PerkinElmer Inc.: Overview

Table 54 PerkinElmer Inc.: Product Portfolio

Table 55 PerkinElmer Inc.: Key Developments

Table 56 Merck KGaA: Overview

Table 57 Merck KGaA: Product Portfolio

Table 58 Merck KGaA: Key Developments

Table 59 F. Hoffmann-La Roche Ltd.: Overview

Table 60 F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 61 F. Hoffmann-La Roche Ltd.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Western Blotting Processors Market Share, By Product, 2021 & 2029 (%)

Figure 2 Global Western Blotting Processors Market Share, By Application, 2021 & 2029 (%)

Figure 3 Global Western Blotting Processors Market Share, BY END User, 2021 & 2029 (%)

Figure 4 Global Western Blotting Processors Market Share, By 0, 2021 & 2029 (%)

Figure 5 Global Western Blotting Processors Market Share, By 0, 2021 & 2029 (%)

Figure 6 Global Western Blotting Processors Market Share, By Region, 2021 & 2029 (%)

Figure 7 Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 8 Global Western Blotting Processors Market Y-o-Y Growth, By Product, 2021-2029 (%)

Figure 9 Consumables: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 10 Instruments: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 11 Global Western Blotting Processors Market Y-o-Y Growth, By Application, 2021-2029 (%)

Figure 12 Biomedical & Biochemical Research: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 13 Disease Diagnostic Agriculture: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 14 Others: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 15 Global Western Blotting Processors Market Y-o-Y Growth, BY END User, 2021-2029 (%)

Figure 16 Academic & Research Institutes: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 17 Pharmaceutical & Biotechnology Companies: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 18 Diagnostic Centers: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 19 Others: Global Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 20 Global Western Blotting Processors Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 21 North America Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 22 North America Western Blotting Processors Market Share, By Product, 2021 & 2029 (%)

Figure 23 North America Western Blotting Processors Market Share, By Application, 2021 & 2029 (%)

Figure 24 North America Western Blotting Processors Market Share, BY END User, 2021 & 2029 (%)

Figure 25 North America Western Blotting Processors Market Share, By Country, 2021 & 2029 (%)

Figure 26 South America Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 27 South America Western Blotting Processors Market Share, By Product, 2021 & 2029 (%)

Figure 28 South America Western Blotting Processors Market Share, By Application, 2021 & 2029 (%)

Figure 29 South America Western Blotting Processors Market Share, BY END User, 2021 & 2029 (%)

Figure 30 South America Western Blotting Processors Market Share, By Country, 2021 & 2029 (%)

Figure 31 Europe Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 32 Europe Western Blotting Processors Market Share, By Product, 2021 & 2029 (%)

Figure 33 Europe Western Blotting Processors Market Share, By Application, 2021 & 2029 (%)

Figure 34 Europe Western Blotting Processors Market Share, BY END User, 2021 & 2029 (%)

Figure 35 Europe Western Blotting Processors Market Share, By Country, 2021 & 2029 (%)

Figure 36 Asia-Pacific Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 37 Asia-Pacific Western Blotting Processors Market Share, By Product, 2021 & 2029 (%)

Figure 38 Asia-Pacific Western Blotting Processors Market Share, By Application, 2021 & 2029 (%)

Figure 39 Asia-Pacific Western Blotting Processors Market Share, BY END User, 2021 & 2029 (%)

Figure 40 Asia-Pacific Western Blotting Processors Market Share, By Country, 2021 & 2029 (%)

Figure 41 Middle East & Africa Western Blotting Processors Market Value, 2020-2029 ($ Million)

Figure 42 Middle East & Africa Western Blotting Processors Market Share, By Product, 2021 & 2029 (%)

Figure 43 Middle East & Africa Western Blotting Processors Market Share, By Application, 2021 & 2029 (%)

Figure 44 Middle East & Africa Western Blotting Processors Market Share, BY END User, 2021 & 2029 (%)

Figure 45 Bio-Rad Laboratories, Inc.: Financials

Figure 46 Bio-Techne Corporation: Financials

Figure 47 Advansta Inc.: Financials

Figure 48 Cell Signaling Technology: Financials

Figure 49 Li-Cor Biosciences: Financials

Figure 50 Cytoskeleton Inc.: Financials

Figure 51 GE Healthcare: Financials

Figure 52 PerkinElmer Inc.: Financials

Figure 53 Merck KGaA: Financials

Figure 54 F. Hoffmann-La Roche Ltd.: Financials